Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic-determinants of Protease Inhibitor Pharmacology
NCT01388543Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Sep 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by University of Colorado Denver. Started Sep 2006; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01388543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01388543.